National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 30319-30320 [2023-10009]
Download as PDF
<![CDATA[
30319
Federal Register / Vol. 88, No. 91 / Thursday, May 11, 2023 / Notices
Estimated
number of
respondents
Data collection instrument(s)
Number of
annual
responses per
respondent
Average
burden hour
per response *
Total annual
burden
(current) **
Pre-Application Package to Medical Staff .............................................
Initial Application Package to Medical Staff and Privileges ..................
Reappointment Application Package to Medical Staff and Privileges ..
Affiliation Verification .............................................................................
Education Verification ............................................................................
Malpractice Verification .........................................................................
Peer Reference Verification ..................................................................
500
878
2,212
4,225
3,289
2,535
6,180
1
1
1
1
1
1
1
.50 (30 min) ...........
1 (60 min) ..............
0.50 (30 min) .........
.25 (15 min) ...........
.25 (15 min) ...........
.25 (15 min) ...........
.25 (15 min) ...........
250
878
1,106
1,056
822
634
1,545
Total ...............................................................................................
19,819
........................
................................
6,291
For ease of understanding:
* Average Burden Hour per Response are provided in actual minutes.
** Total Annual Burden (Current) are provided in hours.
ddrumheller on DSK120RN23PROD with NOTICES1
Annual number of respondents and
average burden hour were factored
based on total IHS providers
credentialed and privileged Calendar
Year (CY) 22, accreditation
requirements with estimates of
verification per applicant, and
respondent estimate time of completion
in the paragraphs above.
There are no capital costs, operating
costs, and/or maintenance costs to
respondents.
Requests for Comments: Your written
comments and/or suggestions are
invited on one or more of the following
points:
(a) Whether the information collection
activity is necessary to carry out an
agency function;
(b) Whether the agency processes the
information collected in a useful and
timely fashion;
(c) The accuracy of the public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information);
(d) Whether the methodology and
assumptions used to determine the
estimates are logical;
(e) Ways to enhance the quality,
utility, and clarity of the information
being collected; and
(f) Ways to minimize the public
burden through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
P. Benjamin Smith,
Deputy Director, Indian Health Service.
[FR Doc. 2023–09998 Filed 5–10–23; 8:45 am]
BILLING CODE 4165–16–P
VerDate Sep<11>2014
17:07 May 10, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Investigator
Award to Support Mentoring of Early Career
Researchers From Diverse Backgrounds.
Date: June 15–16, 2023.
Time: 10:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7353,
Bethesda, MD 20892, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Dated: May 5, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10011 Filed 5–10–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Fellowships in
Diabetes Endocrinology and Metabolism.
Date: June 12, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7021, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–3993,
tathamt@niddk.nih.gov.
E:\FR\FM\11MYN1.SGM
11MYN1
30320
Federal Register / Vol. 88, No. 91 / Thursday, May 11, 2023 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 5, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2023–10009 Filed 5–10–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group; Genome Research Study Section.
Date: June 1, 2023.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Human Genome Research Institute,
6700B Rockledge Drive, Room 3188,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3188, Bethesda, MD 20892, (301) 594–
4280, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: May 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10014 Filed 5–10–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:07 May 10, 2023
Jkt 259001
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Schizophrenia and Related Disorders During
Mid- to Late-Life (R01 & R21).
Date: June 8, 2023.
Time: 10:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: May 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10016 Filed 5–10–23; 8:45 am]
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: June 21, 2023.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Director’s Update, NCI Updates
and Legislative Update.
Place: National Institutes of Health, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Amy Williams, Acting
Director, NCI, Office of Advocacy Relations,
National Cancer Institute, NIH, 31 Center
Drive, Building 31, Room 10A28, Bethesda,
MD 20892, (301) 496–9723, williaam@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: NCRA: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10008 Filed 5–10–23; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Cancer Institute; Notice of
Meeting
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\11MYN1.SGM
11MYN1
]]>Agencies
[Federal Register Volume 88, Number 91 (Thursday, May 11, 2023)]
[Notices]
[Pages 30319-30320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Fellowships in Diabetes
Endocrinology and Metabolism.
Date: June 12, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas A. Tatham, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-3993, [email protected].
[[Page 30320]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: May 5, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-10009 Filed 5-10-23; 8:45 am]
BILLING CODE 4140-01-P
